Sachie Otsuki

680 total citations
5 papers, 233 citations indexed

About

Sachie Otsuki is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sachie Otsuki has authored 5 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Sachie Otsuki's work include Cancer-related Molecular Pathways (2 papers), Fibroblast Growth Factor Research (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). Sachie Otsuki is often cited by papers focused on Cancer-related Molecular Pathways (2 papers), Fibroblast Growth Factor Research (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). Sachie Otsuki collaborates with scholars based in Japan. Sachie Otsuki's co-authors include Takeshi Sagara, Masakazu Yashiro, Kenjiro Ito, Hiroshi Sootome, Akihiro Miura, Kimihiro Ito, Hirokazu Ohsawa, Kaoru Funabashi, Kazuhiko Yonekura and Hiroshi Hirai and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Sachie Otsuki

5 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sachie Otsuki Japan	5	143	76	56	50	29	5	233
Jin Lu China	9	75 0.5×	54 0.7×	12 0.2×	39 0.8×	21 0.7×	38	222
Qunying Wu China	10	243 1.7×	58 0.8×	13 0.2×	45 0.9×	7 0.2×	15	351
Anna Kohlmann United States	7	161 1.1×	40 0.5×	29 0.5×	59 1.2×	10 0.3×	10	300
Sharad K. Verma United States	12	144 1.0×	24 0.3×	17 0.3×	95 1.9×	66 2.3×	27	400
Pavel Dunaev Russia	11	122 0.9×	78 1.0×	24 0.4×	77 1.5×	6 0.2×	32	293
Ruoxuan Hei China	7	150 1.0×	126 1.7×	12 0.2×	22 0.4×	18 0.6×	14	292
Aigul Galembikova Russia	11	142 1.0×	85 1.1×	27 0.5×	96 1.9×	7 0.2×	41	338
Stuart Ince Germany	9	208 1.5×	102 1.3×	30 0.5×	53 1.1×	4 0.1×	21	291
Jared Bearss United States	6	164 1.1×	60 0.8×	14 0.3×	34 0.7×	5 0.2×	11	286
Islam Baiev United States	5	239 1.7×	143 1.9×	30 0.5×	10 0.2×	7 0.2×	12	336

Countries citing papers authored by Sachie Otsuki

Since Specialization

Citations

This map shows the geographic impact of Sachie Otsuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachie Otsuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachie Otsuki more than expected).

Fields of papers citing papers by Sachie Otsuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachie Otsuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachie Otsuki. The network helps show where Sachie Otsuki may publish in the future.

Co-authorship network of co-authors of Sachie Otsuki

This figure shows the co-authorship network connecting the top 25 collaborators of Sachie Otsuki. A scholar is included among the top collaborators of Sachie Otsuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachie Otsuki. Sachie Otsuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Ito, Satoru, Sachie Otsuki, Hirokazu Ohsawa, et al.. (2023). Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use. ACS Medicinal Chemistry Letters. 14(4). 396–404. 16 indexed citations

2.

Sootome, Hiroshi, Hidenori Fujita, Kenjiro Ito, et al.. (2020). Futibatinib Is a Novel Irreversible FGFR 1–4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors. Cancer Research. 80(22). 4986–4997. 137 indexed citations

3.

Satô, Yoshiyuki, T Sugimoto, Kaori Kamijo, et al.. (2009). Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(16). 4673–4678. 46 indexed citations

4.

Sagara, Takeshi, Sachie Otsuki, Toshifumi Kimura, et al.. (2006). Identification of a Novel 4-Aminomethylpiperidine Class of M₃Muscarinic Receptor Antagonists and Structural Insight into Their M₃Selectivity. Journal of Medicinal Chemistry. 49(19). 5653–5663. 8 indexed citations

5.

Shimamura, Tadashi, et al.. (2006). Identification of potent 5-pyrimidinyl-2-aminothiazole CDK4, 6 inhibitors with significant selectivity over CDK1, 2, 5, 7, and 9. Bioorganic & Medicinal Chemistry Letters. 16(14). 3751–3754. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact